| 2024 | P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial
| JAMA NETWORK OPEN |
| 2024 | Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial | DIABETES OBESITY & METABOLISM |
| 2024 | Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial | CIRCULATION |
| 2023 | Association Between Body Mass Index and Clinical Outcomes According to Diabetes in Patients Who Underwent Percutaneous Coronary Intervention
| KOREAN CIRCULATION JOURNAL |
| 2023 | Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial | ATHEROSCLEROSIS |
| 2023 | Association of Prophylactic Distal Perfusion Cannulation With Mortality in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation | AMERICAN JOURNAL OF CARDIOLOGY |
| 2023 | Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
| SCIENTIFIC REPORTS |
| 2023 | Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
| BMJ-BRITISH MEDICAL JOURNAL |
| 2023 | Perioperative Antiplatelet Strategy in Patients Undergoing Noncardiac Surgery Within One Year After Percutaneous Coronary Intervention | AMERICAN JOURNAL OF MEDICINE |
| 2023 | Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial
| ECLINICALMEDICINE |
| 2023 | Efficacy of Percutaneous Coronary Intervention With Synergy Stents in Patients Aged ≥75 Years: 1-Year Clinical Outcomes from the Synergy Elderly Registry | AMERICAN JOURNAL OF CARDIOLOGY |
| 2023 | Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial | JAMA CARDIOLOGY |
| 2023 | Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease
| CIRCULATION JOURNAL |
| 2023 | Clinical implication of ticagrelor monotherapy in patients with small vessel coronary artery disease: results from the TICO randomized trial
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2023 | Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents
| CARDIOLOGY JOURNAL |
| 2023 | Impact of intravascular ultrasound in acute myocardial infarction patients at high ischemic risk | REVISTA ESPANOLA DE CARDIOLOGIA |
| 2023 | Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
| 2023 | A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia
| AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS |
| 2023 | Device Effectiveness for Femoropopliteal Artery Disease Treatment: An Analysis of K-VIS ELLA Registry | JACC-CARDIOVASCULAR INTERVENTIONS |
| 2023 | Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY |
| 2023 | Sex Differences in Midterm Prognostic Implications of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents in East Asian Patients: Results From the PTRG-DES (Platelet Function and Genotype-Related Long-Term Prognosis in Drug-Eluting Stent-Treated Patients With Coronary Artery Disease) Consortium
| JOURNAL OF THE AMERICAN HEART ASSOCIATION |
| 2023 | Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis | EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY |
| 2023 | Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial
| ECLINICALMEDICINE |
| 2023 | Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
| 2023 | Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2023 | Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention | JACC-CARDIOVASCULAR INTERVENTIONS |
| 2023 | Effects of Hypertension on Two-Year Outcomes According to Glycemic Status in Patients With Acute Myocardial Infarction Receiving Newer-Generation Drug-Eluting Stents | ANGIOLOGY |
| 2023 | Stent expansion evaluated by optical coherence tomography and subsequent outcomes
| SCIENTIFIC REPORTS |
| 2023 | Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2023 | Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial | EUROPEAN HEART JOURNAL |
| 2023 | Assessment of fractional flow reserve in intermediate coronary stenosis using optical coherence tomography-based machine learning
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2022 | Sex difference after acute myocardial infarction patients with a history of current smoking and long-term clinical outcomes: Results of KAMIR Registry
| CARDIOLOGY JOURNAL |
| 2022 | A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention | JOURNAL OF INVASIVE CARDIOLOGY |
| 2022 | Reduced Mortality With Antiplatelet Therapy Deescalation After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis | CIRCULATION-CARDIOVASCULAR INTERVENTIONS |
| 2022 | Prediabetes versus type 2 diabetes in patients with acute myocardial infarction and current smoking | AMERICAN JOURNAL OF THE MEDICAL SCIENCES |
| 2022 | Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium | JACC-CARDIOVASCULAR INTERVENTIONS |
| 2022 | A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia
| CLINICAL THERAPEUTICS |
| 2022 | Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2022 | Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: A randomized multicenter trial
| MEDICINE |
| 2022 | Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study
| CARDIOLOGY JOURNAL |
| 2022 | Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2022 | Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial | EUROINTERVENTION |
| 2022 | Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial | LANCET |
| 2022 | ST-elevation versus non-ST-elevation myocardial infarction after combined use of statin with renin-angiotensin system inhibitor: Data from the Korea Acute Myocardial Infarction Registry
| CARDIOLOGY JOURNAL |
| 2022 | Procedural Characteristics of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention and Their Clinical Implications
| JOURNAL OF THE AMERICAN HEART ASSOCIATION |
| 2022 | Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study | ATHEROSCLEROSIS |
| 2022 | Computational Fractional Flow Reserve From Coronary Computed Tomography Angiography-Optical Coherence Tomography Fusion Images in Assessing Functionally Significant Coronary Stenosis
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2022 | Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium
| YONSEI MEDICAL JOURNAL |
| 2022 | Impact of New-Onset Persistent Left Bundle Branch Block on Reverse Cardiac Remodeling and Clinical Outcomes After Transcatheter Aortic Valve Replacement
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2022 | Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
http://orcid.org/0000-0003-2493-066X
(35189204900)
